Coastlands Capital reports acquisition of $805,944.1123 in Pasithea Therapeutics common shares
KTTA•Coastlands Capital, a 10% owner of Pasithea Therapeutics, purchased 1,667,514 common shares. Its indirect beneficial ownership rose to 5,502,549 shares, with purchase prices of $0.4956, $0.4989 and $0.47 per share.
1. Share purchase
A beneficial ownership filing showed that Coastlands Capital, a 10% owner, purchased 1,667,514 common shares of Pasithea Therapeutics. The purchases were made at $0.4956, $0.4989 and $0.47 per share, and indirect beneficial ownership rose to 5,502,549 common shares.




